Echocardiography for the assessment of myocardial viability.
The identification of viable myocardium in the setting of acute myocardial infarction or chronic coronary artery disease with reduced left ventricular function has important prognostic and therapeutic implications. Many noninvasive methods have been used to assess viability, and recently, dobutamine stress echocardiography has been studied for this purpose. Dobutamine stress echocardiography is a safe, accessible, and relatively inexpensive technique. Moreover, its accuracy for detecting viability approaches that of positron emission tomography and thallium scintigraphy. In addition to dobutamine stress echocardiography, other echocardiographic techniques, such as myocardial contrast echocardiography and dipyridamole stress echocardiography, are being developed to delineate viability. In the future, echocardiographic methods may identify viability with enough accuracy to allow us to better select patients for revascularization procedures when the indications are otherwise unclear.
Lualdi
J C
JC
Charles A. Dana Research Institute, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
Douglas
P S
PS
D000318:Adrenergic beta-Agonists; D002908:Chronic Disease; D003327:Coronary Disease / Q000000981:diagnostic imaging* / Q000473:pathology; D004176:Dipyridamole; D004280:Dobutamine; D004452:Echocardiography; D006801:Humans; D009203:Myocardial Infarction / Q000000981:diagnostic imaging* / Q000473:pathology; D009204:Myocardial Revascularization; D009206:Myocardium / Q000473:pathology*; D018579:Patient Selection; D011379:Prognosis; D019275:Radiopharmaceuticals; D012449:Safety; D013794:Thallium Radioisotopes; D014022:Tissue Survival; D014055:Tomography, Emission-Computed; D014665:Vasodilator Agents; D016277:Ventricular Function, Left
D000318:Adrenergic beta-Agonists; D019275:Radiopharmaceuticals; D013794:Thallium Radioisotopes; D014665:Vasodilator Agents; D004280:Dobutamine; D004176:Dipyridamole